Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2026)
Q32 Bio's (QTTB) quarterly Other Non-Current Assets came in at $325000.0 in Q1 2026, down 49.77% year-on-year from $647000.0 in Q1 2025, and down 49.77% quarter-over-quarter from $647000.0 in Q4 2025.
Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Q32 Bio's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $325000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 49.77% year-over-year to $325000.0 in Q1 2026; TTM through Mar 2026 was $325000.0, a 49.77% decrease from a year earlier, with the FY2025 full-year figure at $647000.0, up 457.76% from the prior year.
- Other Non-Current Assets fell to $325000.0 in Q1 2026 per QTTB's latest filing, from $647000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.6 million in Q4 2023 and bottomed at $12000.0 in Q2 2024.
- The 5-year median for Other Non-Current Assets is $647000.0 (2024), against an average of $966818.2.
- Across the five-year window, Other Non-Current Assets sank 97.95% in 2024 and surged 4650.0% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $276000.0 in 2022, then soared by 1946.01% to $5.6 million in 2023, then sank by 97.95% to $116000.0 in 2024, then jumped by 457.76% to $647000.0 in 2025, then sank by 49.77% to $325000.0 in 2026.
- Per Business Quant, the three latest QTTB Other Non-Current Assets figures stand at $325000.0 (Q1 2026), $647000.0 (Q4 2025), and $647000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | 325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Sep 30, 2025 | 647,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 647,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 647,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 5.65 Mn |
| Mar 31, 2022 | 276,000.00 |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 1.27 Mn |
| Jun 30, 2021 | 1.27 Mn |
| Mar 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 1.27 Mn |
| Sep 30, 2020 | 1.27 Mn |
| Jun 30, 2020 | 1.27 Mn |
| Mar 31, 2020 | 1.27 Mn |
| Dec 31, 2019 | 1.27 Mn |